Addendum questionnaire to June Focus On: Tadalafil
Get the latest industry news, event updates, and more from Managed healthcare Executive.
FDA Approves Eydenzelt, Additional Eylea Biosimilar
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
Repatha Now Available for Approximately 60% Off List Price
Strong Results for a New System for Delivering Gemcitabine in Bladder Cancer Patients
Novartis to Offer Cosentyx to Cash Paying Patients at a 55% Discount
Novo Nordisk Resubmits BLA for Once-Weekly Insulin for Type 2 Diabetes